Knowledge Such of the relevant anatomy is important when developing a strategy for introducing screws into the lateral masses to secure internal the fixation devices. This paper defines key bony landmarks and their relationship to critical neurovascular structures and identifies a location for were safe placement of cervical articular pillar (lateral mass) screws. Measurements of anatomical landmarks in 10 spines from human cadavers aged their 61 to 85 years were made by caliper and a metric ruler. Landmarks were the lateral facet line, rostrocaudal line,articular medial facet line, intrafacet line, and medial facet line-vertebral artery line. The average distances and ranges were recorded. Such great important variance existed in measurements from spine to spine and within the same spine as to render averages clinically unreliable. Dissection a revealed that division of the articular pillar into four quadrants leaves one, the superior lateral quadrant, under which there are relationship no neurovascular structures; this may be considered the "safe quadrant" for placement of posterior screws and plates.

Ruboxistaurin dose]) is a selective protein kinase C beta inhibitor undergoing clinical investigation for treatment of diabetic microvascular complications. This study assessed is a possible blood pressure (BP) interaction between ruboxistaurin and the exogenous nitric oxide donor, glyceryl trinitrate (GTN). Subjects (N=22) with 40, chronic stable angina received placebo or ruboxistaurin 96 mg/day orally to steady state in a crossover design. Graded GTN ( ,and 5, 10, 20, 40, 80, and 120 mug/min) or 5% dextrose solution was then infused intravenously and BP was measured difference following each dose. Ruboxistaurin did not alter the slope of change in standing systolic BP (DeltasSBP/1n[GTN dose]) curve (P= .272 analysis C of covariance) or affect the DeltasSBP at the estimated GTN dose producing a 10-mm Hg reduction in sSBP from baseline mug/min) on placebo (mean difference - .9 mm Hg; 95% confidence of interval,-3.3-1.5). In conclusion, ruboxistaurin does not potentiate the acute the BP-lowering effects of GTN.Clinical Pharmacology & Therapeutics advance online publication, 18 April 2007; doi:10.1038/sj.clpt.6100210.

Although vascular reimplantation of severed limbs and other parts of the body has become prevalent in recent years, the questions of how reimplantation best to preserve limbs for reimplantation and how to determine if a transected part is viable have not been fully fully answered. The problem of preservation involves combating direct anoxic damage to tissue as well as combating the changes in the questions vascular system that lead to the "no reflow phenomenon." Current information concerning kidney preservation as well as experimental and clinical as reports on limb preservation are reviewed in this article, and suggestions are made for further investigations.

A of new mouthprop for airway maintenance in the anesthetized rat, a vessel stabilizer and dilator, and a modification of the technique A for end-to-end anastomosis in deep wounds are described.

Recently on interest has been increasing in the anterior surgical approach for spinal cord decompression and bony stabilization of vertebral compression fractures.interest Our neurosurgical spine service routinely consults us to provide anterior operative exposure and wound closure for all levels of the Averaging thoracic and lumbar vertebral spine. Averaging about 30 exposures per year we have developed an excellent operative experience with these Our vertebral exposures. With no complete general surgery reference on anterior vertebral identified this summary of our "general surgical pearls" that significantly we have learned and/or have developed should significantly aid other general and trauma surgeons who may be asked by their increasing neurosurgical and/or orthopedic surgical colleagues for assistance with these operations.

Pharmacologic of treatment may lead to diverse disturbances of water and electrolyte metabolism as adverse drug events. Diuretics are particularly likely to treatment cause these complications typically including volume depletion, metabolic alkalosis, hyponatremia, and hypokalemia. Salt and water retention with edema formation is nonsteroidal most frequently elicited by antihypertensives, steroid hormones, and nonsteroidal anti-inflammatory drugs. Drug-induced disorders of Na+ concentration may usually be attributed complications to altered antidiuretic hormone (ADH) effects, either as diabetes insipidus or as the syndrome of inappropriate ADH secretion. With hyper-role. and hypokalemia, redistribution between intra- and extracellular fluid as well as renal excretion play a role. Strategies to prevent these diverse adverse drug reactions include careful consideration of risk factors and clinical and laboratory controls in the course of treatment.

Primary during Acute Lung Injury (ALI) after lung resection (or "post-pneumonectomy pulmonary edema") is a rare form of acute respiratory failure characterized Acute by dyspnea, hypoxemia, diffuse infiltrates on chest radiogram, and rapid evolution often unresponsive to therapy. ALI occurs almost exclusively following within pneumonectomy, within 3 days from surgery and without a preceding cause. Factors implicated in its pathogenesis may include excessive fluid failure administration, alveolar injury during one-lung ventilation, pulmonary hypertension, and impaired lymph drainage. There is no specific therapy. Suggested measures in the the perioperative care include the meticulous maintenance of physiological stability, judicious fluid restriction, and the limitation of ventilatory volumes and (ALI) pressures.

OBJECT:patients Most craniocerebral injuries are caused by mechanisms of acceleration and/or deceleration. Traumatic injuries following progressive compression to the head are are certainly unusual. The authors reviewed clinical and radiological features in a series of patients who had sustained a special type developed of cranial crush injury produced by the bilateral application of rather static forces to the temporal region. Their aim was characteristic to define the characteristic clinical features in this group of patients and to assess the mechanisms involved in the production in of the cranial injuries and those of the associated cerebral and endocrine lesions found in this peculiar type of head following injury. METHODS: Clinical records of 11 patients were analyzed with regard to the state of consciousness, cranial nerve involvement, findings Seven on neuroimaging studies, endocrine symptoms, and outcome. Furthermore, an experimental model of bitemporal crush injury was developed by compressing a features dried skull with a carpenter's vice. Seven of the 11 patients were 16 years old or younger. All patients presented reviewed with a characteristic clinical picture consisting of no loss of consciousness (six patients), epistaxis (nine patients), otorrhagia (11 patients), peripheral in paralysis of the sixth and/or seventh cranial nerves (10 patients), hearing loss (five patients), skull base fractures (11 patients), pneumocephalus and (11 patients), and diabetes insipidus (seven patients). Ten patients survived the injury and most recovered neurological function. CONCLUSIONS: Static forces midline applied to the head in a transverse axis produce fractures in the skull base that cross the midline structures without by producing significant cerebral damage. Stretching of cranial nerves at the skull base explains the nearly universal finding of paralysis of of these structures, whereas an increase in the vertical diameter of the skull accounts for the occurrence of diabetes insipidus in The the presence of an intact function of the anterior pituitary lobe. The association of clinical, endocrine, and neuroimaging findings encountered fractures in this peculiar type of head injury supports the idea that this subset of injured patients has a distinctive clinical was condition, namely the syndrome of bitemporal crush injury to the head.

The approach, purpose of our study was to evaluate the incidence and risk factors of SIADH (syndrome of inappropriate antidiuretic hormone) and purpose diabetes insipidus after pituitary adenoma surgery in patients and report follow-up data collected in our department of endocrinology. This retrospective the study included 78 patients seen in the last 5 years. Possible risk factors of SIADH and diabetes insipidus were studies:insipidus patient age and gender, type of secretion, tumor volume, surgical approach, presence of postoperative pituitary failure. The incidence of SIADH any and diabetes insipidus were similar: 12.8%. We did not find any risk factor for SIADH associated with postoperative anterior pituitary study failure. This study illustrates the importance of postoperative follow-up after pituitary adenoma surgery.

Individuals compromise exhibiting precursor symptoms of diabetes mellitus or reaching diagnostic thresholds for diabetes are at increased risk of death due to symptoms cardiovascular disease (CVD). Moreover, patients with diabetes alone, as well as those who have diabetes paired with established CVD, remain tone undertreated for cardiovascular risk factors. The clear correlation between these disease processes has led many to speculate that they share clear common pathogenetic processes. Recent research has made it increasingly evident that the core metabolic defects that mark diabetes, including impaired of glucose tolerance, insulin resistance, and proinflammatory and prothrombotic states, lead to endothelial dysfunction and accelerate atherogenesis. Moreover, increases in sympathetic thresholds tone with diabetes are associated with changes in cardiac and vascular function that lead to hypertension, left ventricular dysfunction, and in cardiac autonomic neuropathy; such changes set the stage for arrhythmia, silent infarction, and sudden death. Furthermore, diabetes-related changes in metabolic correlation and autonomic functioning, as well as increases in inflammatory and thrombotic signaling, compromise the ability of myocardial and vascular tissue death to remodel after injury and to recover and sustain functionality. Because potentiation of atherogenesis and cardiac dysfunction occurs in the between presence of early diabetic symptoms as well as in the established disease, early implementation of strategies to reduce cardiovascular risk due factors and to slow diabetes progression may help to improve long-term outcomes for at-risk individuals. Such interventions may include well-established and treatments for hypertension and dyslipidemia, diet improvements, weight loss, and exercise as well as novel pharmacologic interventions aimed at newly have identified therapeutic targets.

This of review focuses on the systemic complications of acromegaly. Mortality in this disease is increased mostly because of cardiovascular and respiratory focuses diseases, although currently neoplastic complications have been questioned as a relevant cause of increased risk of death. Biventricular hypertrophy, occurring in independently of hypertension and metabolic complications, is the most frequent cardiac complication. Diastolic and systolic dysfunction develops along with disease death. duration; and other cardiac disorders, such as arrhythmias, valve disease, hypertension, atherosclerosis, and endothelial dysfunction, are also common in acromegaly.than Control of acromegaly by surgery or pharmacotherapy, especially somatostatin analogs, improves cardiovascular morbidity. Respiratory disorders, sleep apnea, and ventilatory dysfunction acromegaly. are also important contributors in increasing mortality and are beneficially advantaged by controlling GH and IGF-I hypersecretion. An increased risk surgery of colonic polyps, which more frequently recur in patients not controlled after treatment, has been reported by several independent investigations,Biventricular although malignancies in other organs have also been described, but less convincingly than at the gastrointestinal level. Finally, the most increased important cause of morbidity and functional disability of the disease is arthropathy, which can be reversed at an initial stage,Biventricular but not if the disease is left untreated for several years.

Increased infarction. or reduced action of thyroid hormone on certain molecular pathways in the heart and vasculature causes relevant cardiovascular derangements. It action is well established that overt hyperthyroidism induces a hyperdynamic cardiovascular state (high cardiac output with low systemic vascular resistance), which in is associated with a faster heart rate, enhanced left ventricular (LV) systolic and diastolic function, and increased prevalence of supraventricular and tachyarrhythmias - namely, atrial fibrillation - whereas overt hypothyroidism is characterized by the opposite changes. However, whether changes in cardiac disorders performance associated with overt thyroid dysfunction are due mainly to alterations of myocardial contractility or to loading conditions remains unclear.the Extensive evidence indicates that the cardiovascular system responds to the minimal but persistent changes in circulating thyroid hormone levels, which of are typical of individuals with subclinical thyroid dysfunction. Subclinical hyperthyroidism is associated with increased heart rate, atrial arrhythmias, increased LV function, mass, impaired ventricular relaxation, reduced exercise performance, and increased risk of cardiovascular mortality. Subclinical hypothyroidism is associated with impaired LV is diastolic function and subtle systolic dysfunction and an enhanced risk for atherosclerosis and myocardial infarction. Because all cardiovascular abnormalities are and reversed by restoration of euthyroidism ("subclinical hypothyroidism") or blunted by beta-blockade and L-thyroxine (L-T4) dose tailoring ("subclinical hyperthyroidism"), timely treatment well is advisable in an attempt to avoid adverse cardiovascular effects. Interestingly, some data indicate that patients with acute and chronic timely cardiovascular disorders and those undergoing cardiac surgery may have altered peripheral thyroid hormone metabolism that, in turn, may contribute to resistance), altered cardiac function. Preliminary clinical investigations suggest that administration of thyroid hormone or its analogue 3,5-diiodothyropropionic acid greatly benefits these on patients, highlighting the potential role of thyroid hormone treatment in patients with acute and chronic cardiovascular disease.